BIOMAT Database Logo BIOMAT Database Logo

[Microbiologic diagnosis of Helicobacter pylori and its resistance to antibiotics]. 1998

O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Madrid.

From March 1995 to February 1996 a total of 386 gastroduodenal biopsies were processed for microbiological diagnosis of Helicobacter pylori which included culture, Gram staining and urease test. For susceptibility studies to five antimicrobial agents, 35 additional gastroduodenal biopsies (n = 421) were added. There were 272 (70.4%) positive cultures, 220 (56.9%) samples with positive urase test and 244 (63.2%) with positive result in Gram-staining; both tests were statistically significant compared with culture (p < 0.05). Considering culture as the reference method, sensitivity and specificity values for the urease test were 77.0% and 92.1% and for Gram staining 86.7% and 92.9%, respectively. A total of 11 isolates were recovered from the 35 biopsies processed only for culture. Susceptibility testing of 283 isolates (272 + 11) was performed to the following antimicrobials: amoxicillin, metronidazole, clarithromycin, azythromycin and tetracycline. Resistance to metronidazole was 25.4% and the corresponding values for clarithromycin and azithromycin 9.5%. No resistance to amoxicillin or tetracycline was observed. Urease test and Gram staining are two easy-to-perform tests and when taken together allow the microbiological diagnosis of Helicobacter pylori infection. Culture should be performed to know the evolution of resistance to antimicrobials used for treatment of this infection.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014510 Urease An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5. Phytourease,Urea Amidohydrolase,Amidohydrolase, Urea
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Resistance of Helicobacter pylori to antibiotics.
April 1997, Alimentary pharmacology & therapeutics,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Resistance of Helicobacter pylori to antibiotics and its impact on treatment options.
June 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
January 2013, Gut,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
September 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
[Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
October 2006, Zhonghua yi xue za zhi,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37.
June 2011, Antimicrobial agents and chemotherapy,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Epidemiology of Helicobacter pylori Resistance to Antibiotics (A Narrative Review).
July 2023, Antibiotics (Basel, Switzerland),
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
October 2005, Zhonghua yi xue za zhi,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Antibiotics resistance rate of Helicobacter pylori in Bhutan.
September 2013, World journal of gastroenterology,
O López Bartolomé, and A Morán Vasallo, and J A Ramírez Armengol, and J J Picazo de la Garza
Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What's new?
June 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie,
Copied contents to your clipboard!